{"id":"https://openalex.org/W2042715134","doi":"https://doi.org/10.1007/bf01998969","title":"Ampiroxicam, an anti-inflammatory agent which is a prodrug of piroxicam","display_name":"Ampiroxicam, an anti-inflammatory agent which is a prodrug of piroxicam","publication_year":1993,"publication_date":"1993-07-01","ids":{"openalex":"https://openalex.org/W2042715134","doi":"https://doi.org/10.1007/bf01998969","mag":"2042715134","pmid":"https://pubmed.ncbi.nlm.nih.gov/8304243"},"language":"en","primary_location":{"id":"doi:10.1007/bf01998969","doi":"https://doi.org/10.1007/bf01998969","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf01998969","pdf_url":null,"source":{"id":"https://openalex.org/S55943811","display_name":"Inflammation Research","issn_l":"1023-3830","issn":["1023-3830","1420-908X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Agents and Actions","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110180422","display_name":"Thomas J. Carty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Carty","raw_affiliation_strings":["Department of Immunology and Infectious Disease, Pfizer Inc, Groton, CT 06340","Department of Immunology and Infectious Disease, Central Research, Pfizer Inc, Groton, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology and Infectious Disease, Pfizer Inc, Groton, CT 06340","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Immunology and Infectious Disease, Central Research, Pfizer Inc, Groton, U.S.A","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040776399","display_name":"Anthony Marfat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Marfat","raw_affiliation_strings":["Department of Medicinal Chemistry, Central Research, Pfizer Inc, 06340, Groton, CT, U.S.A","Department of Medicinal Chemistry, Central Research, Pfizer Inc, Groton, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Central Research, Pfizer Inc, 06340, Groton, CT, U.S.A","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Medicinal Chemistry, Central Research, Pfizer Inc, Groton, U.S.A","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Peter F. Moore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter F. Moore","raw_affiliation_strings":["Department of Immunology and Infectious Disease, Central Research, Pfizer Inc, 06340, Groton, CT, U.S.A","Department of Immunology and Infectious Disease, Central Research, Pfizer Inc, Groton, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology and Infectious Disease, Central Research, Pfizer Inc, 06340, Groton, CT, U.S.A","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Immunology and Infectious Disease, Central Research, Pfizer Inc, Groton, U.S.A","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083005270","display_name":"Fred C. Falkner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fred C. Falkner","raw_affiliation_strings":["Department of Drug Metabolism, Central Research, Pfizer Inc, 06340, Groton, CT, U.S.A","Department of Drug Metabolism, Central Research, Pfizer Inc, Groton, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism, Central Research, Pfizer Inc, 06340, Groton, CT, U.S.A","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Drug Metabolism, Central Research, Pfizer Inc, Groton, U.S.A","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081356213","display_name":"Thomas M. Twomey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas M. Twomey","raw_affiliation_strings":["Department of Drug Metabolism, Central Research, Pfizer Inc, 06340, Groton, CT, U.S.A","Department of Drug Metabolism, Central Research, Pfizer Inc, Groton, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism, Central Research, Pfizer Inc, 06340, Groton, CT, U.S.A","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Drug Metabolism, Central Research, Pfizer Inc, Groton, U.S.A","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111473293","display_name":"Albert Weissman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Albert Weissman","raw_affiliation_strings":["Department of General Pharmacology, Central Research, Pfizer Inc, 06340, Groton, CT, U.S.A","Department of General Pharmacology, Central Research, Pfizer Inc, Groton, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of General Pharmacology, Central Research, Pfizer Inc, 06340, Groton, CT, U.S.A","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of General Pharmacology, Central Research, Pfizer Inc, Groton, U.S.A","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":3.6566,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.93609285,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"39","issue":"3-4","first_page":"157","last_page":"165"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11905","display_name":"Veterinary Pharmacology and Anesthesia","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/piroxicam","display_name":"piroxicam","score":0.9990000128746033},{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.7979999780654907},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.8629999756813049},{"id":"https://openalex.org/keywords/prostaglandin-synthesis-inhibition","display_name":"prostaglandin synthesis inhibition","score":0.8339999914169312},{"id":"https://openalex.org/keywords/adjuvant-induced-arthritis","display_name":"adjuvant-induced arthritis","score":0.8820000290870667},{"id":"https://openalex.org/keywords/paw-edema","display_name":"paw edema","score":0.9279999732971191},{"id":"https://openalex.org/keywords/analgesic-activity","display_name":"analgesic activity","score":0.8180000185966492},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7350000143051147},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.3479999899864197},{"id":"https://openalex.org/keywords/species-differences","display_name":"species differences","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C2778139025","wikidata":"https://www.wikidata.org/wiki/Q408676","display_name":"Piroxicam","level":3,"score":0.9467630982398987},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.8673528432846069},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6405214071273804},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.572433352470398},{"id":"https://openalex.org/C2779703632","wikidata":"https://www.wikidata.org/wiki/Q581996","display_name":"Anti-inflammatory","level":2,"score":0.44656071066856384},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.31117844581604004},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06004706025123596},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000001","descriptor_name":"Calcimycin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000882","descriptor_name":"Haplorhini","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001169","descriptor_name":"Arthritis, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001711","descriptor_name":"Biotransformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004487","descriptor_name":"Edema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004487","descriptor_name":"Edema","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007408","descriptor_name":"Intestinal Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011448","descriptor_name":"Prostaglandin Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011451","descriptor_name":"Prostaglandin-Endoperoxide Synthases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013843","descriptor_name":"Thiazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013843","descriptor_name":"Thiazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016227","descriptor_name":"Benzoquinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/bf01998969","doi":"https://doi.org/10.1007/bf01998969","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf01998969","pdf_url":null,"source":{"id":"https://openalex.org/S55943811","display_name":"Inflammation Research","issn_l":"1023-3830","issn":["1023-3830","1420-908X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Agents and Actions","raw_type":"journal-article"},{"id":"pmid:8304243","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8304243","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Agents and actions","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1853539513","https://openalex.org/W1894654833","https://openalex.org/W1964670934","https://openalex.org/W1970329936","https://openalex.org/W1981819970","https://openalex.org/W1997787821","https://openalex.org/W2005941883","https://openalex.org/W2006171635","https://openalex.org/W2008574207","https://openalex.org/W2014079949","https://openalex.org/W2018037953","https://openalex.org/W2021138632","https://openalex.org/W2026337603","https://openalex.org/W2041044217","https://openalex.org/W2059574384","https://openalex.org/W2062176029","https://openalex.org/W2065115139","https://openalex.org/W2073223955","https://openalex.org/W2073711060","https://openalex.org/W2084098167","https://openalex.org/W2086608397","https://openalex.org/W2087205127","https://openalex.org/W2093555201","https://openalex.org/W2145776454","https://openalex.org/W2157628281","https://openalex.org/W2316692721","https://openalex.org/W2324422647","https://openalex.org/W2332834340","https://openalex.org/W2395734146","https://openalex.org/W2411799458","https://openalex.org/W2463034656","https://openalex.org/W2467055078","https://openalex.org/W2860464085"],"related_works":["https://openalex.org/W2062176029","https://openalex.org/W2149335724","https://openalex.org/W2900855958","https://openalex.org/W2029783736","https://openalex.org/W2016674637","https://openalex.org/W2065115139","https://openalex.org/W2413521102","https://openalex.org/W2077442828","https://openalex.org/W2397764712","https://openalex.org/W2007002110"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}